Cinitapride is a substituted benzamide dopamine receptor antagonist effective in the
treatment of gastroesophageal reflux and a variety of gastrointestinal motility disorders.
It generates strong procholinergic activity in the gastrointestinal tract by elevating the
serotonergic transmission in the mysenteric plexus.
serotonin-norepinephrine reuptake inhibitor, antidepressant
A novel prokinetic benzamide-stimulating gastrointestinal motility agent and antiucer agent. It acts as an agonist of the 5-HT1 and 5-HT4 receptors and as an antagonist of the 5-HT2 receptors (1,2,3).
ChEBI: Cinitapride is an aromatic ether and a C-nitro compound.
